title: Pfizer Inc. (PFE) Announces Positive Results From its Phase 3 HER2CLIMB-05 Trial
source: Yahoo
date: 2025-10-21
url: https://finnhub.io/api/news?id=361f560000dd037c0974b676540981dc95a221fd751888c454b2b145919e073e
​Pfizer Inc. (NYSE:PFE) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October 14, Pfizer Inc. (NYSE:PFE) announced positive results from its Phase 3 HER2CLIMB-05 trial. ​The trial tested the kinase inhibitor TUKYSA with first-line combination therapy for patients with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer. […]
